These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18355133)

  • 1. Safety and pharmokinetics of triamcinolone hexacetonide in rabbit eyes.
    Abd-El-Barr MM; Albini TA; Carvounis PE; He F; Manzano RP; Chevez-Barrios P; Wensel TG; Wu SM; Holz ER
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):197-205. PubMed ID: 18355133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
    Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
    Yi NY; Davis JL; Salmon JH; Gilger BC
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina.
    Dierks D; Lei B; Zhang K; Hainsworth DP
    Arch Ophthalmol; 2005 Nov; 123(11):1563-9. PubMed ID: 16286619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.
    Ruiz-Moreno JM; Montero JA; Bayon A; Rueda J; Vidal M
    Exp Eye Res; 2007 Feb; 84(2):342-8. PubMed ID: 17141760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes.
    Park HJ; Lee JE; Kim SI; Pak KY; Oum BS; Lee JS; Jung JH; Lee JE
    Retina; 2014 Apr; 34(4):801-6. PubMed ID: 24077088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.
    Myers AC; Bruun A; Ghosh F; Adrian ML; Andréasson S; Ponjavic V
    Curr Eye Res; 2013 Jun; 38(6):649-61. PubMed ID: 23537282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits.
    Ye YF; Gao YF; Xie HT; Wang HJ
    Mol Vis; 2014; 20():629-36. PubMed ID: 24868137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vehicle used for triamcinolone acetonide is toxic to ocular tissues of the pigmented rabbit.
    Zhengyu S; Fang W; Ying F
    Curr Eye Res; 2009 Sep; 34(9):769-76. PubMed ID: 19839870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
    Chin HS; Park TS; Moon YS; Oh JH
    Retina; 2005; 25(5):556-60. PubMed ID: 16077349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model.
    Lee JE; Lim DW; Park HJ; Shin JH; Lee SM; Oum BS
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2924-9. PubMed ID: 21228384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection.
    Nan K; Sun S; Li Y; Qu J; Li G; Luo L; Chen H; Cheng L
    Br J Ophthalmol; 2010 May; 94(5):654-8. PubMed ID: 20447969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration.
    Kim H; Csaky KG; Gravlin L; Yuan P; Lutz RJ; Bungay PM; Tansey G; DE Monasterio F; Potti GK; Grimes G; Robinson MR
    Retina; 2006; 26(5):523-30. PubMed ID: 16770258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal micronized triamcinolone versus triamcinolone acetonide: a clinical and morphological comparative study.
    Salvolini E; Neri P; Orciani M; Di Primio R; Giovannini A
    Int J Immunopathol Pharmacol; 2008; 21(1):181-8. PubMed ID: 18336744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.